Patents by Inventor Yong Mi

Yong Mi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEGATIVE ACTIVE MATERIAL, NEGATIVE ELECTRODE INCLUDING THE SAME, LITHIUM SECONDARY BATTERY INCLUDING NEGATIVE ELECTRODE, AND METHOD OF PREPARING NEGATIVE ACTIVE MATERIAL
    Publication number: 20130004851
    Abstract: A negative active material comprising lithium titanate oxide having an area ratio of a diffraction peak of a (111) plane that appears at 2?-18.3°±0.4 to a diffraction peak of a (311) plane that appears at 2?=35.5°±0.4, in an XRD spectrum, in the range of about 2.2:1 to about 5.5:1, a negative electrode comprising the negative active material, a lithium secondary battery comprising the negative electrode, and a method of preparing the negative active material.
    Type: Application
    Filed: June 11, 2012
    Publication date: January 3, 2013
    Applicant: Samsung SDI Co., Ltd.
    Inventors: Jong-Hee Lee, Yong-Mi Yu, Joa-Young Jeong, Jae-Myung Kim
  • SUBSTITUTED PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
    Publication number: 20130005728
    Abstract: The present invention is directed to a substituted pyrimidine compound of formula (I) or an enantiomer thereof, or a prodrug or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising such a compound. The invention also includes a method of treatment of a patient by the administration of a pharmaceutically effective amount of such a compound.
    Type: Application
    Filed: September 11, 2012
    Publication date: January 3, 2013
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Keith J. HARRIS, Joacy C. AGUIAR, Patrick Wai-Kwok SHUM, Zhicheng ZHAO, Gregory B. POLI, Gregory STOKLOSA, Yong-Mi CHOI-SLEDESKI, Stephan REILING, David STEFANY, Charles GARDNER
  • SUBSTITUTED PYRIMIDINE AS A PROSTAGLANDIN D2 RECEPTOR ANTAGONIST
    Publication number: 20130005741
    Abstract: The present invention is directed to a 2,6-substituted-4-monosubstitutedamino-pyrimidine compound of formula (I): or an enantiomer thereof, or an ester prodrug or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising such a compound. The invention also includes a method of treatment of a patient by the administration of a pharmaceutically effective amount of such a compound.
    Type: Application
    Filed: September 11, 2012
    Publication date: January 3, 2013
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Keith John HARRIS, Joacy C. AGUIAR, Patrick Wai-Kwok SHUM, Zhicheng ZHAO, Gregory B. POLI, Gregory T. STOKLOSA, Yong-Mi CHOI-SLEDESKI, Stephan REILING
  • TREATMENT OF DERMATOLOGICAL ALLERGIC CONDITIONS
    Publication number: 20120309790
    Abstract: A treatment for a dermatological allergic condition is disclosed, using a compound of Formula I:
    Type: Application
    Filed: August 20, 2012
    Publication date: December 6, 2012
    Applicant: SANOFI
    Inventors: Yong Mi CHOI-SLEDESKI, Neil FITCH, Anne MINNICH
  • Voltage stabilization circuit and semiconductor memory apparatus using the same
    Patent number: 8320212
    Abstract: A voltage stabilization circuit of a semiconductor memory apparatus includes an operation speed detecting unit configured to detect an operation speed of the semiconductor memory apparatus to generate a detection signal, and a voltage line controlling unit configured to interconnect a first voltage line and a second voltage line in response to the detection signal.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: November 27, 2012
    Assignee: Hynix Semiconductor Inc.
    Inventors: Yong-Mi Kim, Jeong-Tae Hwang, Jeong-Hun Lee
  • [4-(5-AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-[7-FLUORO-1-(2-METHOXY-ETHYL)-4-TRIFLUOROMETHOXY-1H-INDOL-3-YL]-METHANONE AS AN INHIBITOR OF MAST CELL TRYPTASE
    Publication number: 20120283445
    Abstract: The present invention is directed to an indole benzylamine compound of formula I: useful as an inhibitor of tryptase. In addition, the present invention is directed to the use of the compound for treating a patient suffering from, or subject to, a physiological condition in need of amelioration by inhibition of tryptase, comprising administering to the patient of a therapeutically effective amount of the compound, and to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula I, and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 27, 2012
    Publication date: November 8, 2012
    Applicant: SANOFI
    Inventors: Yong Mi CHOI-SLEDESKI, Nakyen CHOY, Gregory Bernard POLI, John J. SHAY, JR., Patrick Wai-Kwok SHUM, Adam W. SLEDESKI
  • NEGATIVE ELECTRODE ACTIVE MATERIAL, METHOD FOR PREPARING THE SAME AND LITHIUM SECONDARY BATTERY INCLUDING NEGATIVE ELECTRODE ACTIVE MATERIAL
    Publication number: 20120258368
    Abstract: A negative electrode active material, a method of preparing the negative electrode active material and a lithium secondary battery including the negative electrode active material are disclosed. A negative electrode active material includes a lithium titanate, wherein a portion of lithium of the lithium titanate is substituted by at least one selected from the group consisting of Sr, Ba, a mixture thereof and an alloy thereof, and thus a lithium secondary battery including the negative electrode active material may improve high-rate discharge characteristics.
    Type: Application
    Filed: February 2, 2012
    Publication date: October 11, 2012
    Applicant: SAMSUNG SDI CO., LTD.
    Inventors: Jong-Hee LEE, Yong-Mi Yu, Joa-Young Jeong, Jae-Myung Kim
  • LITHIUM TITANATE, NEGATIVE ELECTRODE INCLUDING THE LITHIUM TITANATE, AND SECONDARY LITHIUM BATTERY CONTAINING THE ELECTRODE
    Publication number: 20120244439
    Abstract: A negative electrode for a lithium secondary battery that includes, as a negative active material, a lithium titanate (Li4Ti5O12) compound containing 0.004 parts by weight or less of phosphorous (P) and 0.007 parts by weight or less of potassium (K) based on 100 parts by weight of lithium titanate, a binder, and a conductive agent, and a lithium secondary battery including the negative electrode.
    Type: Application
    Filed: December 13, 2011
    Publication date: September 27, 2012
    Applicant: SAMSUNG SDI CO., LTD.
    Inventors: Yong-Mi Yu, Jong-Hee Lee
  • [4 [4-(AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-(1H-PYRROLO-PYRIDIN-YL)-METHANONES AND SYNTHESIS THEREOF
    Publication number: 20120245199
    Abstract: The present invention relates herein to compounds and compositions for the treatment and amelioration of inflammatory disease. Specifically the present invention relates to compounds that having a tryptase inhibition activity and the intermediates thereof, pharmaceutical compositions comprising such compounds, and a method of treating subjects suffering from a condition disease or disorder that can be ameliorated by the administration of an inhibitor of tryptase.
    Type: Application
    Filed: June 5, 2012
    Publication date: September 27, 2012
    Applicant: SANOFI
    Inventors: Yong Mi CHOI-SLEDESKI, Thaddeus R. NIEDUZAK, Gregory B. POLI, Patrick Wai-Kwok SHUM, Gregory T. STOKLOSA, Zhicheng ZHAO
  • INDOLYL-PIPERIDINYL BENZYLAMINES AS BETA-TRYPTASE INHIBITORS
    Publication number: 20120245161
    Abstract: The present invention discloses and claims a series of substituted indolyl-piperidinyl benzylamines of the formula wherein R1, R2, R4 and R5 are as described herein. More specifically, the compounds of this invention are inhibitors of ?-tryptase and are, therefore, useful as pharmaceutical agents. Additionally, this invention also discloses methods of preparation of substituted indolyl-piperidinyl benzylamines.
    Type: Application
    Filed: June 5, 2012
    Publication date: September 27, 2012
    Applicant: SANOFI
    Inventors: Yong Mi CHOI-SLEDESKI, Guyan LIANG, Thaddeus R. NIEDUZAK, Gregory B. POLI, Patrick Wai-Kwok SHUM, Gregory T. STOKLOSA, Zhicheng ZHAO
  • TROPINONE BENZYLAMINES AS BETA-TRYPTASE INHIBITORS
    Publication number: 20120238600
    Abstract: The present invention discloses and claims a series of substituted tropinone benzylamines of formula (I): The compounds of this invention are inhibitors of ?-tryptase and are, therefore, useful as pharmaceutical agents. Additionally, this invention also discloses methods of preparation of substituted tropinone benzylamines.
    Type: Application
    Filed: June 5, 2012
    Publication date: September 20, 2012
    Applicant: SANOFI
    Inventors: Yong Mi CHOI-SLEDESKI, Guyan LIANG, Patrick Wai-Kwok SHUM
  • PRODRUGS OF [4 [4-(5-AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-(1H-PYRROLO-PYRIDIN-YL)-METHANONES AND SYNTHESIS THEREOF
    Publication number: 20120238573
    Abstract: The present invention relates to substituted 2-amino-N-(4-fluoro-3-{1-[1-(alkyl)-1H-indole-3-carbonyl]-piperidin-4-yl}-benzyl)-acetamides (compounds of formula I) compositions thereof, and their use in the treatment of inflammatory diseases.
    Type: Application
    Filed: June 5, 2012
    Publication date: September 20, 2012
    Applicant: SANOFI
    Inventors: Yong Mi CHOI-SLEDESKI, Gregory B. POLI
  • TREATMENT FOR INFLAMMATORY BOWEL DISEASE
    Publication number: 20120238603
    Abstract: The present invention relates to a method for the treatment of an inflammatory bowel disease by the administration of the compound [4-(5-aminomethyl-2-fluorophenyl)piperidine-1-yl][7-fluoro-1-(2-methoxyethyl)-4-trifluoromethoxy-1H-indol-3-yl]methanone, which may be represented as Formula I: or a corresponding N-oxide, prodrug, pharmaceutically acceptable salt or solvate thereof.
    Type: Application
    Filed: June 5, 2012
    Publication date: September 20, 2012
    Applicant: SANOFI
    Inventors: Anne MINNICH, Eszter BEKASI, Yong Mi CHOI-SLEDESKI
  • IMPEDANCE CONTROL CIRCUIT AND INTEGRATED CIRCUIT CHIP INCLUDING THE SAME
    Publication number: 20120217991
    Abstract: A circuit, including a first impedance unit having an impedance value based on a first impedance code and configured to drive a first node coupled with a resistor with a first voltage, a first code generation unit configured to generate the first impedance code so that an impedance value of the first impedance unit and an impedance value of the resistor are at a ratio of X:Y, dummy impedance units that receive the first impedance code and drive a second node with the first voltage, a second impedance unit having an impedance value based on a second impedance code and configured to drive the second node with a second voltage, and a second code generation unit configured to generate the second impedance code so that an overall impedance value of the dummy impedance units and an impedance value of the second impedance unit are at a ratio of X:Y
    Type: Application
    Filed: December 21, 2011
    Publication date: August 30, 2012
    Inventors: Dong-Wook JANG, Yong-Mi KIM
  • SUBSTITUTED PROPANE PHOSPHINIC ACID DERIVATIVES
    Publication number: 20120208784
    Abstract: The present invention relates to a series of substituted 3-aminopropane phosphinic acid derivatives of formula I: wherein R, R1, P1, P2 and P3 are as defined herein. The compounds of this invention are useful in treating a variety of diseases including but not limited to depression, anxiety, certain psychiatric symptoms, cognitive impairment and schizophrenia.
    Type: Application
    Filed: April 24, 2012
    Publication date: August 16, 2012
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Yong Mi CHOI-SLEDESKI, Julian LEVELL, Gregory Bernard POLI, Mark CZEKAJ, Alan John COLLIS, Roy VAZ
  • SEMICONDUCTOR MEMORY APPARATUS AND METHOD OF TESTING THE SAME
    Publication number: 20120204070
    Abstract: A method of testing a semiconductor memory apparatus is provided. The data alignment units other than the one data align unit being tested are deactivated. Serial data is input to the activated data alignment unit to generate parallel data. The parallel data is decoded. A test mode signal corresponding to the decoded result is enabled to perform the test. Different serial data is input where the test mode signal is enabled to generate and decode parallel data. Both tests are then performed simultaneously based on a test mode signal corresponding to a result of the decoded parallel data.
    Type: Application
    Filed: February 6, 2012
    Publication date: August 9, 2012
    Applicant: Hynix Semiconductor Inc.
    Inventors: Jeong Hun LEE, Yong Mi KIM, Jeong Tae HWANG
  • [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-flouro-1-(2-methoxy-ethyl)-4-trifluorom as an inhibitor of mast cell tryptase
    Patent number: 8217178
    Abstract: The present invention is directed to an indole benzylamine compound of formula I: useful as an inhibitor of tryptase. In addition, the present invention is directed to the use of the compound for treating a patient suffering from, or subject to, a physiological condition in need of amelioration by inhibition of tryptase, comprising administering to the patient of a therapeutically effective amount of the compound, and to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula I, and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: February 16, 2011
    Date of Patent: July 10, 2012
    Assignee: Sanofi
    Inventors: Yong Mi Choi-Sledeski, Nakyen Choy, Gregory Bernard Poli, John J. Shay, Jr., Patrick Wai-Kwok Shum, Adam W. Sledeski
  • DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]- 1H-INDOL-3-YL]-METHANONES
    Publication number: 20120142735
    Abstract: The present invention extends to a compound of formula I: or a pharmaceutically acceptable salt of said compound, or a pharmaceutical composition comprising the compound of formula I and a pharmaceutically acceptable carrier. The invention is also directed to the use of a compound of formula I as an inhibitor of tryptase and for treating a patient suffering from, or subject to, a physiological condition in need of amelioration by an inhibitor of tryptase. The invention further includes methods for the preparation of a compound of formula I.
    Type: Application
    Filed: February 14, 2012
    Publication date: June 7, 2012
    Applicant: SANOFI
    Inventors: Yong- Mi CHOI-SLEDESKI, Charles J. GARDNER, Guyan LIANG, Gregory B. POLI, Patrick Wai-Kwok SHUM, Grzegory T. STOKLOSA, Zhicheng ZHAO
  • Substituted propane phosphinic acid derivatives
    Patent number: 8183231
    Abstract: The present invention relates to a series of substituted 3-aminopropane phosphinic acid derivatives of formula I: wherein R, R1, P1, P2 and P3 are as defined herein. The compounds of this invention are useful in treating a variety of diseases including but not limited to depression, anxiety, certain psychiatric symptoms, cognitive impairment and schizophrenia.
    Type: Grant
    Filed: October 24, 2006
    Date of Patent: May 22, 2012
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Yong Mi Choi-Sledeski, Julian Levell, Gregory Bernard Poli, Mark Czekaj, Alan John Collis, Roy Vaz
  • Memory structures and methods for video codec
    Patent number: 8180195
    Abstract: A memory device for storing a plurality of macroblocks may include a plurality of memory banks. Each macroblock may include m*n pixel data, wherein m is a positive integer, and wherein n also is a positive integer. The plurality of memory banks is adapted to store the pixel data, and wherein each memory bank is sized to store rows of m pixel data. An image processing system may include: a memory adapted to store a plurality of macroblocks; and a video codec. The memory may include a plurality of memory banks. Each memory bank may be sized to store rows of m pixel data. The video codec may be adapted to encode pixel data read from the memory. The video codec also may be adapted to decode the pixel data read from the memory.
    Type: Grant
    Filed: February 27, 2008
    Date of Patent: May 15, 2012
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Yong-Mi Lee, Jung-Sun Kang